✦ LIBER ✦

PCV84 Resource Utilization and Costs for Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Programme for the Austrian Setting

✍ Scribed by F.M. Fruhwald; A.D. Vavrovsky

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of candesartan on New York Heart

✍ E. O’Meara; S. Solomon; J. McMurray 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 36 KB

The data monitoring experience in the Ca

✍ Stuart Pocock; Duolao Wang; Lars Wilhelmsen; Charles H. Hennekens 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Prevention of atrial fibrillation in pat

✍ Anique Ducharme; Karl Swedberg; Marc A. Pfeffer; Alain Cohen-Solal; Christopher 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 238 KB

Effects of Candesartan on Mortality and

✍ Sricharan Kantipudi; Atul Khasnis 📂 Article 📅 2004 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 117 KB

Effects of candesartan on mortality and

✍ Marc A Pfeffer; Karl Swedberg; Christopher B Granger; Peter Held; John JV McMurr 📂 Article 📅 2003 🏛 The Lancet 🌐 English ⚖ 129 KB

ACE Inhibitor Intolerance and Lessons Le

✍ Domenic A. Sica 📂 Article 📅 2004 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 305 KB